We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    Miriam Mintzer
Previous Study | Return to List | Next Study

Effects of Meditation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01827033
Recruitment Status : Terminated (The Principal Investigator is leaving Johns Hopkins.)
First Posted : April 9, 2013
Last Update Posted : September 16, 2015
Information provided by (Responsible Party):
Miriam Mintzer, Johns Hopkins University

Brief Summary:
This research is being done to learn about the effects of doing meditation (sitting quietly and concentrating) on people's ability to pay attention and be relaxed.

Condition or disease Intervention/treatment
Meditation Training Behavioral: meditation training

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 6 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : March 2013
Primary Completion Date : June 2013
Study Completion Date : June 2013

Arm Intervention/treatment
meditation training Behavioral: meditation training

Primary Outcome Measures :
  1. computerized attention task [ Time Frame: within 1 week after training ]
    discrimination score on the continuous performance task

Secondary Outcome Measures :
  1. stress questionnaires [ Time Frame: within 1 week after training ]
  2. mindfulness questionnaire [ Time Frame: within 1 week after training ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • aged 18-55
  • currently enrolled in methadone maintenance program

Exclusion Criteria:

  • history of: a severe medical or psychiatric condition (except substance abuse; e.g., schizophrenia); brain trauma affecting cognitive functioning
  • prior experience with meditation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01827033

United States, Maryland
BPRU, Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States, 21224
Sponsors and Collaborators
Johns Hopkins University
Principal Investigator: Miriam Z Mintzer, PhD Johns Hopkins University

Responsible Party: Miriam Mintzer, Associate Professor, Johns Hopkins University
ClinicalTrials.gov Identifier: NCT01827033     History of Changes
Other Study ID Numbers: NA_00082735
First Posted: April 9, 2013    Key Record Dates
Last Update Posted: September 16, 2015
Last Verified: November 2013